Atlas Trials

Autologous Gene Therapy for Artemis-Deficient SCID

Clinical trial NCT03538899 · RECRUITING

Trial details

NCT number
NCT03538899
Sponsor
University of California, San Francisco
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Severe Combined Immunodeficiency
Start date
2018-05-31
Primary completion
2038-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.